NEIBC

The New England-Israel Business Council

Industry. Innovation. Entrepreneurship.
New England and Israel have a lot in common.

The New England-Israel Business Council is a non-profit, non-governmental, membership-supported organization that connects companies and organizations in New England to Israel, the fastest growing economy among developed nations in the world and the largest center for innovation and entrepreneurship in technology and life sciences outside the United States.

With a similar industrial focus and an entrepreneurial culture, New England and Israel share a natural economic affinity. Academic initiatives, as well as state and federal policy initiatives, reinforce and nurture scientific and business collaboration between the two regions.

The NEIBC promotes this collaboration. Our goals are to:

Foster cooperation, investment opportunities and business relationships between Israeli and New England companies
Support business, academic and government organizations in New England and Israel wishing to develop mutual relationships
Encourage and assist Israeli companies seeking to establish a US presence in New England

Key Industries

Life Sciences and Health Care
Cleantech
Homeland Security
Information Communications and Technology

NEIBC Executive Board and Advisors

Executive Board

*President* Yuval Malinsky CEO Vigorous Mind, Inc.	David Barone Principal Boston Medtech Advisors NEIBC Life Sciences Committee Chair	Udi Mokady CEO CyberArk NEIBC Information Technology and Communications Committee Chair
*Secretary* Gil Breiman Partner Burns & Levinson LLP	David Crosby Counsel, Nixon Peabody NEIBC Cleantech Committee Chair	Avi Nevel President, Nevel International NEIBC Rhode Island Representative
*Treasurer* Bruce Levine Partner Levine, Katz, Nannis + Solomon, PC	Adi Golani Director of Economic Affairs Consulate General of Israel to New England	Perry Newman President Atlantica Group NEIBC Maine Representative
	Nancy Katz Director, Israel Advocacy Combined Jewish Philanthropies	Don Perrin Principal Cambridge Business Advisors NEIBC Chair, Special Projects
	B. Minde Kornfeld Independent Business Counsel NEIBC Membership Committee Chair	Mel Prenovitz CEO EndoSphere Surgical NEIBC Marketing Committee Chair

Directors

Shy Baranov Partner ZAG/SW	Gill Fishman Owner Gill Fishman Design	Jerry Schaufeld Professor of Management Worcester Polytechnic Institute
Yael Biran Managing Director Mintz Levin Israel Business	Robert Gottlieb Principal, RMG Associates	Ilan Segev Vice President, Private Banking Credit Suisse
Robin JR Blatt Principal Biogenuity	Tamar Guy Executive Director America-Israel Chamber of Commerce	Edward Shapiro Edward A. Shapiro, P.C.
Tami Durst Executive Director NEIBC	Yigal Koltin Independent Biopharmaceutical Consultant	Albert Sherman Vice Chancellor, University of Massachusetts Medical School (retired)
Gary Engelson Partner Lowrie, Lando & Anastasi		Jeff Stonberg Principal Stonberg Holdings Corp.

Advisory Board

Yair Shiran
Economic Minister to North America
Government of Israel

Jack M. Wilson
President

University of Massachusetts System

2010 Life Sciences Summit Committee Members

Oved Amitay Vice President and General Manager, Gaucher Disease Portfolio Genzyme Corporation	Joyce College Business Development Automated Medical Instruments	Yuval Malinsky CEO Vigorous Mind President NEIBC
Shy Baranov Partner ZAG/SW LLP	Samuel Dinnar Managing Director DSMVC	Gil Ben Menachem Director Business Development Teva Pharmaceuticals
David Barone Principal Boston MedTech Advisors NEIBC Life Sciences Committee Chair	Sara Dolinsky NEIBC 2010 Summit Coordinator	Raphael Nir President SBH Sciences
Martin Becker Biotechnology Consultant	Tami Durst Executive Director NEIBC	Michal Preminger Executive Director Office of Technology Development Harvard University Medical School
Yael Biran Managing Director Mintz Levin Israel Business	David Dyekman Member Greenberg Traurig	Melvin Prenovitz CEO EndoSphere Surgical
Robin Blatt Principal Applied Biogenuity	Neal Farber CEO NeuroHealing	Yair Schindel Vice President Marketing, Clinical and Business Development Omniguide
Kathryn Bloom Retired Biogen Idec (retired)	Elkan Gamzu enERGetics Biopharmaceutical Consultancy	Chen Schor Vice President, Business Development Global Branded Products Teva Pharmaceuticals
Gil Breiman Partner Burns & Levinson	Robert Gottlieb CEO RMG Associates	Jay Schwartz Life Sciences Business Consultant
Howard Brick COO MedPanels	Henry Kay Partner Medica Venture Partners	Ben Shamir Business Development and Fundraising Consultant
Ari Buchler Senior Vice President and General Counsel Phase Forward	Yigal Koltin Biopharmaceutical Consultant Israel and MA	Martin Sklar President and CEO Automated Medical Instruments
Michael Chorev Associate Professor of Medicine Harvard Medical School	Jon Kravetz Member Mintz Levin	Tal Wenderow Co-Founder, Executive Vice President Marketing & Business Development Corindus
Dalia Cohen Chief Scientific Officer Rosetta Genomics	Rami Lotem Business Development Consultant Israel

Pre-registration is required. Limited space remaining.

"...It is extremely impressive to see the kind of people that you have attracted to the Summit from the big pharma and the venture capital community, and the great service you are offering to Israeli companies..."

Jonathan Solomon
President and CEO
NeuroPhage Pharmaceuticals, Inc.

2010 SUMMIT

Graphic Design - Gill Fishman Associates

Public Relations - Ball Consulting Group

Website Design - eastsideGRAPHICS

NEIBC

The New England-Israel Business Council

Industry. Innovation. Entrepreneurship.
New England and Israel have a lot in common.

Key Industries